InsidersTradesSigma
Total declarations
Companies
▲ Purchases (4 ops.)
▼ Sales (0 ops.)
Insider track record
ExecutiveDisclosed buys
4
Disclosed sells
0
T+90 hit rate
100%
T+90 mean return
+20.3%
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the full record of transactions filed by McAvoy David R., Conseiller Juridique et Directeur de la Conformité. Officer active across 4 companies, notably Brickell Biotech, Inc.. In total, 6 filings have been recorded. Split: 4 buys · 0 sell. Total volume traded: €45k. Activity tracked since 17 May 2021. The latest transaction was filed on 23 July 2021 (Acquisition). Regulator: SEC (Form 4). All data is openly available.
Declarations6 total
16,741 sharesOrdinary SharesSEC:0000950170-25-034670:0
20,000 sharesCommon StockSEC:0001628280-23-033914:0
18,124 shares@ US$0.6697100.0% of flowCommon StockSEC:0000819050-21-000124
Ideal exit: 19 Apr 2022 (T+270)
18,124 shares@ US$0.669729.6% of flowCommon StockSEC:0000819050-21-000124:0
Ideal exit: 19 Apr 2022 (T+270)
18,622 shares@ US$0.8035.2% of flowCommon StockSEC:0001062993-21-004867:0
Ideal exit: 11 Feb 2022 (T+270)
18,622 shares@ US$0.8035.2% of flowCommon StockSEC:0001062993-21-004867
Ideal exit: 11 Feb 2022 (T+270)
6 of 6 declarations
About McAvoy David R.
David R. McAvoy is General Counsel and Chief Compliance Officer at Brickell Biotech, Inc., a company specializing in the development of biopharmaceutical therapies. In this role, he is responsible for legal and compliance matters, ensuring that the company adheres to applicable regulations.
